StockData
ATXIOTCPharmaceutical PreparationsFiscal year ends December 31

AVENUE THERAPEUTICS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.43+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
$1.42M
P/E (TTM)
–
Dividend yield
–

AVENUE THERAPEUTICS, INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Avenue Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.